Concepedia

Author

Venessa Tsang

The University of SydneyORCID

Also Known As

Tsang, Venessa, Tsang, Venessa H. M., V H M Tsang, V Tsang, V. Tsang, V.H. Tsang, Venessa H M Tsang, Venessa H Tsang, Venessa H. M. Tsang, Venessa H. Tsang

93

Publications

1.8K

Citations

24

H-Index

47

Concepts

All Affiliations

The University of SydneyRoyal North Shore HospitalMelanoma Institute AustraliaMater Health ServicesRoyal Prince Alfred Hospital
VT

About

Venessa Tsang is an author at The University of Sydney specializing in medicine, pathology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

354

2

Natural Sciences

2

2

111

3

Biochemistry

2

2

111

4

Cell Biology

2

2

76

5

Health Sciences

1

1

19

Venessa Tsang

×

22

Publications

1.2K

Citations

18

H-Index

YearCitations

Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment

Christopher A. Muir, Roderick Clifton‐Bligh, Georgina V. Long,

The Journal of Clinical Endocrinology & Metabolism

2021

191

The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma

Emma Scott, Georgina V. Long, Alexander Guminski,

European Journal of Endocrinology

2017

146

Checkpoint Inhibitor–Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes

Venessa Tsang, Rachel T. McGrath, Roderick Clifton‐Bligh,

The Journal of Clinical Endocrinology & Metabolism

2019

127

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Zien Zhou, Meg Jardine, Qiang Li,

Stroke

2021

111

Clinical and Molecular Characterization of a Novel PLIN1 Frameshift Mutation Identified in Patients With Familial Partial Lipodystrophy

Kristina Kozusko, Venessa Tsang, William Bottomley,

Diabetes

2014

78

A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis

Talia L. Fuchs, Anthony J. Nassour, Anthony Glover,

The American Journal of Surgical Pathology

2020

76

Thyroid Toxicity Following Immune Checkpoint Inhibitor Treatment in Advanced Cancer

Christopher A. Muir, Alexander M. Menzies, Roderick Clifton‐Bligh,

Thyroid

2020

72

New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen.

V. Westeel, Nevin Murray, Karen A. Gelmon,

Journal of Clinical Oncology

1998

63

Association of Antithyroid Antibodies in Checkpoint Inhibitor–Associated Thyroid Immune–Related Adverse Events

Christopher A. Muir, Cameron Wood, Roderick Clifton‐Bligh,

The Journal of Clinical Endocrinology & Metabolism

2022

63

Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours

Venessa Tsang, Trisha Dwight, D E Benn,

Endocrine Related Cancer

2014

41

Page 1